Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Diabetologia

• Publication date

  1992-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00400918PMID 1563579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyperlipidemia in diabetes mellitus.

  1990cited by this paper
• Nonuniform radiolabeling of VLDL apolipoprotein B: implications for the analysis of studies of the kinetics of the metabolism of lipoproteins containing apolipoprotein B.

  1990cited by this paper
• Mean Time Parameters in Pharmacokinetics

  1989cited by this paper
• Mean Time Parameters in Pharmacokinetics

  1989cited by this paper
• A simple method for the measurement of total and glycated apolipoprotein B and its relevance to apolipoprotein-B metabolism in diabetes mellitus.

  1989cited by this paper
• Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

  1989cited by this paper
• Comparison of Arterial Intimal Clearances of LDL from Diabetic and Nondiabetic Cholesterol‐fed Rabbits: Differences in Intimal Clearance Explained by Size Differences

  1989cited by this paper
• Non-enzymatic glycosylation of low-density lipoprotein. Results of an affinity chromatography method

  1988cited by this paper
• Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes

  1988cited by this paper
• Diabetes and lipoprotein receptors.

  1987cited by this paper
• Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits.

  1987cited by this paper
• Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins

  1987cited by this paper
• Plasma Lipids and Lipoproteins in Diabetes Mellitus

  1987cited by this paper
• Impaired hepatocyte binding, uptake and degradation of glucosylated low-density lipoproteins.

  1986cited by this paper
• Measurement of apolipoprotein B radioactivity in whole blood plasma by precipitation with isopropanol.

  1986cited by this paper
• LIPOPROTEIN ABNORMALITIES IN INSULIN-DEPENDENT DIABETES MELLITUS

  1986cited by this paper
• Role of nonenzymatic glycosylation in atherogenesis

  1986cited by this paper
• Glycosylation of low density lipoprotein in patients with Type I (insulin-dependent) diabetes: Correlations with other parameters of glycaemic control

  1986cited by this paper
• Lipoprotein abnormalities in insulin-dependent diabetes mellitus.

  1986cited by this paper
• Comparison of Three Different Assay Procedures for the Determination of HbA1 with Special Attention to the Influence of Pre-HbA1c, Temperature and Haemoglobin Concentration

  1985cited by this paper
• Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycemic control.

  1985cited by this paper
• Glucosylation of Low-Density Lipoproteins to an Extent Comparable to That Seen in Diabetes Slows Their Catabolism

  1984cited by this paper
• Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus.

  1984cited by this paper
• Interaction of human endothelial cells with elevated glucose concentrations and native and glycosylated low density lipoproteins

  1984cited by this paper
• Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus.

  1983cited by this paper
• Measurement of receptor-independent metabolism of low-density lipoprotein. An application of glycosylated low-density lipoprotein.

  1983cited by this paper
• Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione-treated low density lipoprotein in the measurement of receptor-independent low density lipoprotein catabolism.

  1983cited by this paper
• Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein.

  1983cited by this paper
• Effect of Metabolic Control on Lipid, Lipoprotein, and Apolipoprotein Levels in 55 Insulin-dependent Diabetic Patients: A Longitudinal Study

  1983cited by this paper
• Glycosylation of LDL decreases its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo.

  1982cited by this paper
• Nonenzymatic Glucosylation of Low-Density Lipoprotein Alters Its Biologic Activity

  1982cited by this paper
• Integrated Regulation of Very Low Density Lipoprotein Triglyceride and Apolipoprotein-B Kinetics in Non-insulin-dependent Diabetes Mellitus

  1982cited by this paper
• Nonenzymatic Glycosylation of Low Density Lipoproteins In Vitro: Effects on Cell-interactive Properties

  1981cited by this paper
• Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: Relationship with control

  1981cited by this paper
• Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients.

  1980cited by this paper
• The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages.

  1980cited by this paper
• Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

  1979cited by this paper
• Efficient Trace-labelling of Proteins with Iodine

  1958cited by this paper
• The theory of tracer experiments with 131I-labelled plasma proteins.

  1957cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper

• Cholesterol metabolism in aging simultaneously altered in liver and nervous system

  2022cites this paper
• Methylglyoxal mediated glycation leads to neo-epitopes generation in fibrinogen: Role in the induction of adaptive immune response.

  2021cites this paper
• Filling data gap for nicotinic acid, nicotinate esters and nicotinamide for the determination of permitted daily exposure by a category approach

  2020cites this paper
• Lipoprotein removal mechanisms and aging: implications for the cardiovascular health of the elderly.

  2020cites this paper
• Immunochemical studies on native and glycated LDL - An approach to uncover the structural perturbations.

  2018cites this paper
• OLIVE CAKE OR DATE STONE IN RATIONS OF NEW ZEALAND WHITE RABBITS:-1- THE EFFECT ON GROWTH PERFORMANCE, SOME PHYSIOLOGICAL PARAMETERS AND CARCASS TRAITS

  2014cites this paper
• ASPECT TOXICOLOGIQUE ET PHYSICOCHIMIQUE DU 1,5-DIPENTANAL

  2014cites this paper
• An Immunohistochemical Analysis to Validate the Rationale behind the Enhanced Immunogenicity of D-Ribosylated Low Density Lipo-Protein

  2014cites this paper
• Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation

  2000cites this paper
• Association between low-density lipoprotein composition and its metabolism in non-insulin-dependent diabetes mellitus.

  1999cites this paper
• Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys.

  1998cites this paper
• Diabetic dyslipidaemia.

  1998cites this paper
• Ascorbic acid and diabetes mellitus.

  1996cites this paper
• Modification of lipoproteins in diabetes.

  1996cites this paper
• Nonenzymic glycation of apolipoprotein B in patients with insulin- and noninsulin-dependent diabetes mellitus.

  1995cites this paper
• Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics.

  1994cites this paper
• Insulin and lipoprotein metabolism with special reference to the diabetic state.

  1994cites this paper
• Glycated LDL Concentrations in Non-Diabetic and Diabetic Subjects Measured with Monoclonal Antibodies Reactive with Glycated Apolipoprotein B Epitopes

  1993cites this paper
• The maillard or browning reaction in diabetes

  1993cites this paper
• Glycation and oxidation of human low density lipoproteins reduces heparin binding and modifies charge.

  1993cites this paper